News center | Philippines​

Jul 25, 2019

Philippine General Hospital Uses Philips Technology to Reopen its Sleep Laboratory Services 

Manila, Philippines,  Royal Philips (NYSE: PHG, AEX: PHIA)- The Philippine General Hospital (PGH) has reopened its Sleep Laboratory Services using the Philips Alice 6 LDx Diagnostic sleep system. Advances in medical technology, and appropriate diagnosis and treatment will be accessible to patients affected with Obstructive Sleep Apnea (OSA) at an affordable price. 

 

To assure the quality of the studies, PGH will use one of the latest video polysomnography (Alice-6) in the country, a computerized sleep-wake and physiological monitoring system. With 55 channels, it allows a complete EEG examination to investigate seizures, multiple sleep latency tests and the usual diagnostic or titration studies. It meets the polysomnographic specifications of the American Academy of Sleep Medicine and comes with a video acquisition system to document sleep parasomnias and seizure episodes. 

 

The system, donated by the Green Cross-Jesus Co Ay Tian Foundation, is one of the most advanced machines available in the Philippines obtained through Respicare Enterprises. It facilitates diagnosis and treatment modification during one session. Philips also has a variety of continuous positive airway pressure (CPAP) machines – the machines used to treat OSA – which are more affordable. 

As a seldom-discussed, under-diagnosed condition, OSA is characterized by repeated interruptions in breathing throughout the sleep cycle and prevents oxygen from reaching the lungs1. Symptoms of OSA include choking or gasping for air during sleep, loud and persistent snoring and excessive daytime fatigue and poor concentration during the day. If left untreated, sleep apnea can have serious short and long-term health risks including heart disease, type 2 diabetes, stroke and high blood pressure.  In a recent survey conducted by Philips, even after being diagnosed, 65% of those who reported having sleep apnea have either never used or are no longer using sleep apnea therapy to treat their disease2.

1 Philips: About Sleep Apnea

2 https://www.philips.com/a-w/about/news/archive/standard/news/press/2019/20190307-in-recognition-of-world-sleep-day-philips-presents-its-annual-global-sleep-survey-results.html

 

PGH Sleep Services recently opened to the public and will be in full operation before the year ends. Enquiries can be made at PGH through the Pulmonary Laboratory (Tel: 5518400 local 3157)

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at  www.philips.com/newscenter.  

Click here to read moreClick here to read less

Topics

Contacts

Sheo Rai

Sheo S. Rai

Senior Manager
Brand and Communications
Philips ASEAN Pacific

Media assets

Share on social media

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.